BioSpace News Archive

BridgeBio launched Charlotte, N.C.-based ML Bio Solutions to develop the LGMD2i asset BBP-418, a substrate supplementation therapy.

The following tips from a seasoned recruiter can reduce serious ATS-related errors and help increase the value of the time investment.

Late Wednesday, the company said it is looking to facilitate the sale of its business products in development, as well as its technology.

For new graduates with limited experience, as well as career-changers whose experience is outside the area they now wish to pursue, fighting the underqualified label is tough

100% Single-Dose Protection Observed in Lethal Challenge Model

Acacia Pharma Group plc announces its unaudited interim results for the six-month period ended 30 June 2019.

Evonik Venture Capital has invested in a 3D-printing start-up in China that makes implants for neuro and spine surgery.

Theragnostics announces a licence agreement with AstraZeneca for intellectual property (IP) that enables Theragnostics’ freedom to operate globally in the diagnostic field of certain selected radionuclide-labelled PARPi Polymerase inhibitors) with an option to an exclusive licence for freedom to operate globally in the therapeutic field of certain selected radionuclide-labelled PARPi.

TreeFrog Therapeutics, an expert stem cell company, announces that it has received close to €3M in non-dilutive funding from French and European programs.

Owlstone Medical announced the introduction of a new ReCIVA® Breath Sampler and CASPERTM Portable Air Supply, designed to support internal biomarker discovery programs and those of academic and biopharma clients, and to measure levels of known volatile organic compounds on breath.